Armistice Capital, LLC 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 3:07 pm Sale |
2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Armistice Capital, LLC | 364,000 2.800% |
-392,000 (-51.85%) |
Filing |
| 2020-09-10 4:38 pm Purchase |
2020-08-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Armistice Capital, LLC | 756,000 5.600% |
756,000 (New Position) |
Filing |